Macrophage Membrane‐Reversibly Cloaked Nanotherapeutics for the Anti‐Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis
Small Methods · 2023-09 · 7 (9)
DOI: 10.1002/smtd.202300667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 19.07.2023. Verfasst von Bingchen Shan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. Hauptthemen laut MEDLINE: Antioxidants, Arthritis, Rheumatoid. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 111 Project, Collaborative Innovation Center of Suzhou Nano Science & Technology.
Abstract (Originalsprache)
During rheumatoid arthritis (RA) development, over‐produced proinflammatory cytokines represented by tumor necrosis factor‐α (TNF‐α) and reactive oxygen species (ROS) represented by H 2 O 2 form a self‐promoted cycle to exacerbate the synovial inflammation and tissue damage. Herein, biomimetic nanocomplexes (NCs) reversibly cloaked with macrophage membrane (RM) are developed for effective RA management via dual scavenging of TNF‐α and ROS. To construct the NCs, membrane‐penetrating, helical polypeptide first condenses TNF‐α siRNA (siTNF‐α) and forms the cationic inner core, which further adsorbs catalase (CAT) via electrostatic interaction followed by surface coating with RM. The membrane‐coated NCs enable prolonged blood circulation and active joint accumulation after systemic administration in Zymosan A‐induced arthritis mice. In the oxidative microenvironment of joints, CAT degrades H 2 O 2 to produce O 2 bubbles, which shed off the outer membrane layer to expose the positively charged inner core, thus facilitating effective intracellular delivery into macrophages. siRNA‐mediated TNF‐α silencing and CAT‐mediated H 2 O 2 scavenging then cooperate to inhibit inflammation and alleviate oxidative stress, remodeling the osteomicroenvironment and fostering tissue repair. This study provides an enlightened strategy to resolve the blood circulation/cell internalization dilemma of cell membrane‐coated nanosystems, and it renders a promising modality for RA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
- Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano & Soft Materials (FUNSOM), Collaborative Innovation Center of Suzhou Nano Science & Technology, Soochow University,…
ORCID-Profile: Lichen Yin
Förderung
- National Natural Science Foundation of China
- 111 Project
- Collaborative Innovation Center of Suzhou Nano Science & Technology
- Joint International Research Laboratory of Carbon-Based Functional Materials and Devices
- Suzhou Key Laboratory of Nanotechnology and Biomedicine
- Higher Education Discipline Innovation Project
Zitieren
APA
Shan, B., Zhou, Y., Yin, M., Deng, Y., Ge, C., Liu, Z., Zhou, R., Dong, Q., Zhou, X., & Yin, L. (2023). Macrophage Membrane‐Reversibly Cloaked Nanotherapeutics for the Anti‐Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis. Small Methods, 7(9). https://doi.org/10.1002/smtd.202300667
Vancouver
Shan B, Zhou Y, Yin M, Deng Y, Ge C, Liu Z, et al. Macrophage Membrane‐Reversibly Cloaked Nanotherapeutics for the Anti‐Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis. Small Methods. 2023;7(9). doi:10.1002/smtd.202300667
BibTeX
@article{Shan2023,
author = {Shan, Bingchen and Zhou, Yang and Yin, Mengyuan and Deng, Yekun and Ge, Chenglong and Liu, Zhongmin and Zhou, Renxiang and Dong, Qirong and Zhou, Xiaozhong and Yin, Lichen},
title = {Macrophage Membrane‐Reversibly Cloaked Nanotherapeutics for the Anti‐Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis},
journal = {Small Methods},
year = {2023},
volume = {7},
number = {9},
doi = {10.1002/smtd.202300667}
}
EUVIMED